Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for GLMD
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- LightsOn: @issues $RVNC $GLMD $FTSV $ARDX $ARVN $CNST Might I ask what IBD group 9 is? Also how did you scan to pick the stocks? thanks
- Herb: $GLMD Your NASH Stock of the Day.
- coldevinc: @Herb $GLMD Or as gnashing of teeth for missing out on the bump up ;)
- Herb: @coldevinc $GLMD Exactamundo!
- Herb: $GLMD $RVNC strong biotechs today.
- issues: Looking at biotechs (IBD group 9- excellent~) includes these winners: $RVNC $GLMD $FTSV $ARDX $ARVN $CNST. Thanks for the tips on the two best but they are in the stratosphere! Bought FTSV!
- debeers: $GLMD-Have never come out in favor of a clinical biomed company before. Read up on this israeli company and its special in their research of fatty liver disease.
- debeers: $GLMD--Stifel agrees. Target 35 just came out.
- TRICIA: Biotech Movers+Pipe Updates 07/31: from BIOPHARMCATALYST.com $ACRX Ph3 data Tue 8/1 $NVIV halts trial $AMGN $CLVS $BMY $GLMD $ICPT $SBPH $ZIOP
- woodman: @gwenzee $CATB - $4.00 offering announced after close on Thursday 9/22, dropped to $4.25 the next day, and closed today at $4.63. Could do worse. :-) But that's not what interests me. It's on my list as a possible NASH buyout, or as a mover on irrational NASH one or two-day craze, as companies seem to be interested in the therapeutic area and rumors tend to swirl. Look at $TBRA $GALT $GLMD. (I thought you might have known about it b/c of its phase 2 DMD drug given your interest in $SRPT. That's why I asked.)
- woodman: $CATB $GLMD $GALT $CNAT - Many #NASH / fatty liver disease stocks have been flying post-$TBRA. For example, GLMD GALT CNAT. One I bought is a micro-cap (read: Caution!) $CATB that has moved but not as much. I wonder if this will fly soon.
- woodman: $CATB $GLMD $GALT $CNAT $TBRA #NASH - slight correction. $CABT has moved perhaps in line with some of the others on the lower end, but seems like it has room for a bigger pop.
- gwenzee: @woodman $CATB $GLMD $GALT $CNAT $TBRA $CABT #NASH Did you see my post re: $ACIU???
- woodman: @gwenzee $CATB $GLMD $GALT $CNAT $TBRA $CABT $ACIU #NASH --- Is that the private one that $AGN also bought? I don't see it as a stock that trades.
- TRICIA: $GLMD - @Woodman - unbelievable .... Europe Next week ... Thinly-traded micro cap Galmed Pharmaceuticals (GLMD 25.3%) heads north on double normal volume, albeit on turnover of only ~160K shares. Earlier today, Roth Capital initiated coverage with a Buy rating and $20 price target. The company's lead product candidate is Aramchol, a conjugate of cholic acid and arachidic acid, in development for the treatment of non-alcoholic steatohepatitis (NASH) and the dissolution of gallstones.
- dtoce: $SPY Volume This rally seems a bit light. Unlike the volume seen in some breakouts like: $PRTA $CTRP $CALA $TOUR $RALY $KBH $MFRM $BABY $GLMD The hairs on the back of my neck are standing up a bit... Stops=portfolio protection.
- moneyHoHo: $GLMD has moved a lot, but could move a lot more. Put on radar.
- TRICIA: #NASH and the contenders $CNAT, $ICPT, $GALT,$GLMD, $ACHN,$GILD, $CEMP -- guys keep an eye on all of these ... I posted rock solid infor on this Jan 7 and as mentioned yesterday the EASL (European Liver Conference meets in Autria in Early April) ... I expect some claims and statements by all these candidates --and movement in one direction ... up ...
- TRICIA: #NASH tickers ( .. some of these started moving last week.... keeping a watch .. $CNAT.$GALT,$GILD,$ICPT,$ACHN, $CEMP, and $GLMD .. #EASL15 is in Vienna April 21-25
-
TRICIA: ...
#NASH and the contenders $CNAT, $ICPT, $GALT,$GLMD, $ACHN,$GILD, $CEMP ..earlier,I ranked $GILD 6th in #NASH tx .. now I put them behind only $CNAT whose rank will be confirmed Thursday AH when they reveal data from 3 trials.
While I am impressed ... - TRICIA: $CNAT, $GLMD,$ICPT,$GILD,$ACHN, $GALT ... NASH ...fatty liver disease ...contorversial yes... NASH is the new disease??? No it is the new hype .. the cure?? Diet and Exercise... (Titter buddies were quite critical of my view re NASH and drug treatment) $CNAT is up 25% today (I like this CEO .. and I added to this at ASSLD .. but I sold Friday .grrrrrrr Earlier today, I watched the tiny thin $GLMD start to go .. so it is a day trade...currently up 18% ... Iam up 11% $ICPT ... don't want it ... don't trust CSO or CEO ..and data is squirrelly .. My take on NASH ... get on the bike, and watch these but day or swing trade only..
- TRICIA:
- TRICIA: #AASLID2014 - IT's all about LIVER ..(hideous childhood memory - Mom making LIVER and Onions omg -- gag me :-( Nov. 7-11: American Association for the Study of Liver Disease (AASLD): #NASH $GILD, $CNAT, $ICPT, $GALT, $GLMD, $ALGFT $ALNY,$MDCO $ACHN #HEPC $GILD, $$BMY, $MRK, $ABBV, $ENTA, $RGLS, .. $ACHN no show> re it's NUC? #HEPB $ARWR, $TKMR, $ALNY, $CELG $GILD, $GBIM, $TLOG Looking at these companies, & considering the money being poured into all these very very expensive trials --I'm thinking this is a make or break weekend May we need a LIVER ETF - Call it $GAG (from the Mommy dearest chronicles) Feuerstein posed these questions .. http://adamfeuerstein.tumblr.com/post/101757154622/five-burning-questions-liver-disease-stocks FD - Long GILD, ENTA, TKMR, CNAT, GBIM - I will be in Boston this weekend as a guest of some bio - analysts ...excited to meet them and maybe look for a job.
- woodman: $CNAT/$GLMD/$ICPT - watch other fatty liver disease stocks $CNAT and $GLMD tomorrow due to $ICPT. They could see some action.
- woodman: $GLMD
- woodman: $GALT - In the NASH/liver disease therapeutic area, my hopes and $$ are mostly riding on $ICPT. But as a trade in this TA, I am in $GALT. I like the chart. (Note: I also have a big position in $GILD as a long term hold for many reasons, only one of which is its work on NASH; another one to consider, perhaps, is little guy, $GLMD which may be turning around on the chart since its post-ipo plummet - no position in $GLMD).
- woodman: #LiverDisease stocks are moving today. $ICPT, $GALT (making a new recent high since its dive and staying above the 50 day) and perhaps even $GLMD (first time above it's 21 dEMA since its ipo [barely]).
| Stock Price | $0.38 |
| Change | -2.68% |
| Volume | 21,187 |
Galmed Pharmaceuticals Ltd is a development stage company. The Company is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
Request Video of GLMDAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.12 332.50%
-
$13.26 250.78%
-
$6.37 148.00%
Past Month
Lagging Peers
-
$26.70 -85.08%
-
$6.21 -76.23%
-
$13.87 -57.46%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!